Validating these hypotheses will provide a compelling argument for the use of epigenetic modifying drugs to reverse SOCS1 gene repression to restore cell-intrinsic tumor suppressor functions as well as cell-extrinsic impact on antitumor immunity. The gene discussed is SOCS1; the disease is neoplasm.